IRF9 and unphosphorylated STAT2 cooperate with NF-kB to induce IL-6 expression [42], a cytokine that promotes tumour growth of EGFR-driven GBM in an autocrine and paracrine manner [43]. Here, NFKB1 is linked to neoplasm.